Enanta Pharmaceuticals (ENTA) Current Taxes (2014 - 2018)

Enanta Pharmaceuticals' Current Taxes history runs 5 years deep, the most recent figure standing at $5.9 million for Q4 2018.

• Quarterly Current Taxes fell 42.89% year-over-year to $5.9 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $5.9 million (down 42.89% YoY) and the FY2018 annual result came in at $1.4 million, down 85.07% from the prior year.
• Current Taxes was $5.9 million for Q4 2018 at Enanta Pharmaceuticals, up from $1.4 million in the prior quarter.
• Across five years, Current Taxes topped out at $16.9 million in Q4 2014 and bottomed at $1.2 million in Q3 2015.
• A 5-year average of $6.8 million and a median of $5.6 million in 2018 frame the typical range for Current Taxes.
• Annual changes were most pronounced in 2016 — Current Taxes soared 31.99% — and 2018, when it tumbled 85.07%.
• Enanta Pharmaceuticals' Current Taxes stood at $16.9 million in 2014, then plunged by 70.76% to $4.9 million in 2015, then plunged by 40.45% to $2.9 million in 2016, then surged by 248.64% to $10.3 million in 2017, then slumped by 42.89% to $5.9 million in 2018.
• Business Quant data shows ENTA's Current Taxes at $5.9 million in Q4 2018, $1.4 million in Q3 2018, and $5.4 million in Q1 2018.